We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Community Trust Bancorp
CTBI
$1.41B
| $992K | ﹤0.01% |
23,574
+545
| +2% | +$22.1K |
|
2227
Axsome Therapeutics
AXSM
$10.9B
| $986K | ﹤0.01% |
29,930
+366
| +1% | +$14.3K |
|
|
QADA
2228
DELISTED
QAD Inc.
QADA
| $982K | ﹤0.01% |
11,234
-893
| -7% | -$77.8K |
|
|
GDEN
2229
DELISTED
Golden Entertainment
GDEN
| $979K | ﹤0.01% |
19,949
+779
| +4% | +$36.2K |
|
|
CELL
2230
DELISTED
PhenomeX Inc. Common Stock
CELL
| $975K | ﹤0.01% |
49,830
+4,583
| +10% | +$174K |
|
2231
Cato Corp
CATO
$66.1M
| $968K | ﹤0.01% |
58,551
-7,701
| -12% | -$129K |
|
2232
Madrigal Pharmaceuticals
MDGL
$11.8B
| $966K | ﹤0.01% |
12,113
+234
| +2% | +$20.2K |
|
|
HONE
2233
DELISTED
HarborOne Bancorp
HONE
| $957K | ﹤0.01% |
68,157
+1,570
| +2% | +$21.7K |
|
2234
Invivyd
IVVD
$218M
| $956K | ﹤0.01% |
+22,626
| New | +$840K |
|
|
VRAY
2235
DELISTED
ViewRay, Inc.
VRAY
| $955K | ﹤0.01% |
132,513
+6,351
| +5% | +$40.1K |
|
2236
Upland Software
UPLD
$15.4M
| $953K | ﹤0.01% |
2,850
+135
| +5% | +$50.6K |
|
|
DHIL
2237
DELISTED
Diamond Hill
DHIL
| $951K | ﹤0.01% |
5,416
-1,879
| -26% | -$329K |
|
|
KE
2238
Kimball Electronics
KE
$628M
| $951K | ﹤0.01% |
36,887
+1,015
| +3% | +$23.2K |
|
2239
RPC Inc
RES
$1.3B
| $949K | ﹤0.01% |
195,280
+3,897
| +2% | +$16.3K |
|
2240
Anterix
ATEX
$1.94B
| $947K | ﹤0.01% |
15,596
+598
| +4% | +$35.1K |
|
|
ATRS
2241
DELISTED
Antares Pharma, Inc.
ATRS
| $946K | ﹤0.01% |
259,935
-24,719
| -9% | -$99.9K |
|
2242
Globalstar
GSAT
$10.8B
| $944K | ﹤0.01% |
37,688
+14,423
| +62% | +$354K |
|
2243
Douglas Dynamics
PLOW
$1.02B
| $942K | ﹤0.01% |
25,956
+1,050
| +4% | +$40.5K |
|
|
MRC
2244
DELISTED
MRC Global
MRC
| $940K | ﹤0.01% |
128,013
+2,383
| +2% | +$19.8K |
|
2245
Peapack-Gladstone Financial
PGC
$812M
| $939K | ﹤0.01% |
28,144
+825
| +3% | +$26.5K |
|
|
VRS
2246
DELISTED
Verso Corporation
VRS
| $938K | ﹤0.01% |
45,210
-1,284
| -3% | -$24.8K |
|
2247
Seneca Foods Class A
SENEA
$1.21B
| $936K | ﹤0.01% |
19,410
-3,236
| -14% | -$163K |
|
2248
Scholar Rock
SRRK
$6.44B
| $936K | ﹤0.01% |
28,351
+1,243
| +5% | +$43.5K |
|
2249
V2X
VVX
$2.65B
| $935K | ﹤0.01% |
18,601
+413
| +2% | +$19.5K |
|
2250
A10 Networks
ATEN
$1.95B
| $931K | ﹤0.01% |
69,079
+2,775
| +4% | +$36K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.